Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 17 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lucira Health, Inc. | 59,459 | reported | 01 Jun 2022 | tx 5+205,844−146,385 |
| Quince Therapeutics, Inc. | 29,423 | reported | 02 Jan 2026 | tx 48+4,591,164−1,925,165 |
| Applied Molecular Transport Inc. | 20,000 | reported | 24 May 2022 | tx 10+1,112,694−3 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Quince Therapeutics, Inc. | 29,423 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 47,587 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 14 Dec 2023 | PURCHASE | Quince Therapeutics, Inc. | 22,627 | 1.04 USD | |
| 12 Dec 2023 | PURCHASE | Quince Therapeutics, Inc. | 300 | 1.00 USD | |
| 12 Dec 2023 | PURCHASE | Quince Therapeutics, Inc. | 22,327 | 1.02 USD | |
| 13 Dec 2023 | PURCHASE | Quince Therapeutics, Inc. | 22,627 | 1.00 USD | |
| 06 Dec 2023 | PURCHASE | Quince Therapeutics, Inc. | 19,123 | 1.02 USD | |
| 05 Dec 2023 | PURCHASE | Quince Therapeutics, Inc. | 19,123 | 1.01 USD | |
| 07 Dec 2023 | PURCHASE | Quince Therapeutics, Inc. | 19,123 | 1.01 USD | |
| 30 Nov 2023 | PURCHASE | Quince Therapeutics, Inc. | 14,378 | 0.90 USD | |
| 01 Dec 2023 | PURCHASE | Quince Therapeutics, Inc. | 14,378 | 0.94 USD | |
| 29 Nov 2023 | PURCHASE | Quince Therapeutics, Inc. | 14,378 | 0.98 USD | |
| 31 Aug 2023 | PURCHASE | Quince Therapeutics, Inc. | 41,026 | 1.32 USD | |
| 30 Aug 2023 | PURCHASE | Quince Therapeutics, Inc. | 41,026 | 1.31 USD | |
| 15 Aug 2023 | PURCHASE | Quince Therapeutics, Inc. | 107,886 | 1.32 USD | first after silence |
| 16 Aug 2023 | PURCHASE | Quince Therapeutics, Inc. | 117,348 | 1.29 USD | |
| 17 Aug 2023 | PURCHASE | Quince Therapeutics, Inc. | 24,766 | 1.29 USD | |
| 24 May 2023 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Lucira Health, Inc. | 59,459 | 0.00 USD | deriv |
| 24 May 2022 | GRANT_AWARD | Applied Molecular Transport Inc. | 20,000 | 0.00 USD | deriv |
| 23 May 2022 | PURCHASE | Applied Molecular Transport Inc. | 33,500 | 3.26 USD | |
| 20 May 2022 | PURCHASE | Applied Molecular Transport Inc. | 33,000 | 3.08 USD | first after silence |
2 purchases reported after at least 12 months of silence — most recent on 15 Aug 2023.